OMED

OncoMed Pharmaceuticals, Inc.

OMED

Delisted

OMED was delisted on the 22nd of April, 2019.

66 hedge funds and large institutions have $61M invested in OncoMed Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 13 closing their positions.

2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1 2016 Q4 2016 Q3 2016 Q2 2016 Q1 2015 Q4 2015 Q3 2015 Q2 2015 Q1 2014 Q4 2014 Q3 2014 Q2 2014 Q1 2013 Q4 2013 Q3

Holders

Holders Change

-3

Holders Change %

-4.35%

% of All Funds

1.51%

Holding in Top 10

–

Holding in Top 10 Change

-1

Holding in Top 10 Change %

-100%

% of All Funds

–

New

Increased

Reduced

Closed

Calls

$2K

Puts

–

Net Calls

+$2K

Net Calls Change

-$1K

Top Buyers

1	1 Renaissance Technologies New York	$2.22M
2	2 Susquehanna International Group Bala Cynwyd, Pennsylvania	$282K
3	BC 3 Birchview Capital Burlington, Vermont	$314K
4	SI 4 Sofinnova Investments Menlo Park, California	$213K
5	SIM 5 Spark Investment Management New York	$365K

Top Sellers

1	1 Ameriprise Minneapolis, Minnesota	$968K
2	ASP 2 Adams Street Partners Chicago, Illinois	$0
3	3 Millennium Management New York	$740K
4	ECM 4 Endurant Capital Management San Mateo, California	$0
5	PP 5 PDT Partners New York	$0

#	Name	Market Value	Shares	Shares Change	Shares Change %
26	SI 26 Sofinnova Investments Menlo Park, California	$213K	67,033	+67,033	New
27	27 Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada	$199K	62,600	+2,125	+4%
28	28 Goldman Sachs New York	$198K	62,211	+10,105	+19%
29	29 Northern Trust Chicago, Illinois	$188K	59,010	-7	-0%
30	30 Charles Schwab San Francisco, California	$186K	58,373	+3,276	+6%
31	31 Acadian Asset Management Boston, Massachusetts	$181K	56,793	+56,793	New
32	32 Citadel Advisors Miami, Florida	$174K	54,578	+10,000	+22%
33	OAM 33 Oxford Asset Management Oxford, United Kingdom	$174K	54,672	+21,762	+66%
34	DS 34 DRW Securities Chicago, Illinois	$171K	53,740	+40,000	+291%
35	BFM 35 Boothbay Fund Management New York	$122K	38,432	+38,432	New
36	NSEDCP 36 NJ State Employees Deferred Compensation Plan Trenton, New Jersey	$121K	38,000	–	–
37	37 Tudor Investment Corp Stamford, Connecticut	$101K	31,909	-8,886	-22%
38	38 Wells Fargo San Francisco, California	$88K	27,649	-1,037	-4%
39	39 Bank of New York Mellon New York	$86K	26,953	-1,754	-6%
40	40 Two Sigma Investments New York	$78K	24,537	-36,828	-60%
41	41 State Street Boston, Massachusetts	$75K	23,841	+3,174	+15%
42	ZIM 42 Zacks Investment Management Chicago, Illinois	$69K	21,597	–	–
43	KAM 43 Kazazian Asset Management Fort Lauderdale, Florida	$68K	21,289	+1,777	+9%
44	44 Walleye Trading New York	$67K	20,990	+20,990	New
45	HCM 45 Hodges Capital Management Dallas, Texas	$50K	15,592	–	–
46	BCM 46 BlueCrest Capital Management St Helier, Jersey	$45K	14,275	-18,107	-56%
47	AG 47 Algert Global San Francisco, California	$41K	13,013	-51,976	-80%
48	48 Simplex Trading Chicago, Illinois	$41K	13,059	+13,059	New
49	WS 49 Wedbush Securities Los Angeles, California	$40K	12,500	+12,500	New
50	50 Baird Financial Group Milwaukee, Wisconsin	$38K	12,000	–	–

OncoMed Pharmaceuticals, Inc. OMED

Top Buyers

Top Sellers

OncoMed Pharmaceuticals, Inc.

OMED